Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Jun;26(6):1154-1161.
doi: 10.1007/s11605-022-05280-6. Epub 2022 Mar 1.

Complications Rate Variability after Bariatric Surgery and the Importance of Standardization of a Reporting System

J Eduardo Flores  1 , Ricardo Berrones  1 , Lizbeth Guilbert  1 , Elisa M Sepúlveda  1 , Violeta Madrigal  1 , Jorge Hernández  1 , Carlos Zerrweck  2
Affiliations

Complications Rate Variability after Bariatric Surgery and the Importance of Standardization of a Reporting System

J Eduardo Flores et al. J Gastrointest Surg. 2022 Jun.

Abstract

Background: The rate of early (< 30 days) complications after bariatric surgery has been reported to be 0.4-27.4%. Although the incidence of serious adverse events has decreased with time and experience, controversy regarding how they are reported persists, and the current literature is heterogeneous.

Methods: Data from patients, who underwent primary bariatric surgery (gastric bypass and sleeve gastrectomy) at a single institution between 2012 and 2018, were retrospectively reviewed. Any deviation from a "normal" postoperative course (< 30 days) was identified, and a comparative analysis of early complications according to five models was performed: modified Clavien-Dindo; Longitudinal Assessment of Bariatric Surgery (LABS); Bariatric Surgery Centers of Excellence (BSCOE); American Society for Metabolic and Bariatric Surgery (ASMBS); and Li (major/minor).

Results: A total of 788 patients (83.7% gastric bypass), of whom 8.8% deviated from a "normal" postoperative course, were included. After applying the five classifications, the results were as follows: Clavien-Dindo, 8.8%; LABS, 2.3%; BSCOE, 0.4%; ASMBS, 9.9%; and Li, 11.2%. The incidence of major/severe/adverse outcomes were as follows: Clavien-Dindo, 2.4%; LABS, 2.3%; BSCOE, 0.4%; ASMBS, 6.9%; and Li 9.2%. Minor complications were as follows: Clavien-Dindo, 6.5%; ASMBS, 3%; and Li, 2%. There was no mortality.

Conclusion: Germane heterogeneity was found in reporting of early complications after bariatric surgery. Incidence varied according to classification system applied, and Clavien-Dindo demonstrated accuracy as a reporting model. To avoid bias, standardized reporting should be mandatory, and a more stringent and homogeneous reporting system should be established.

Keywords: Bariatric surgery; Complications; Modified Clavien-Dindo; Obesity surgery; Roux-en-Y gastric bypass; Sleeve gastrectomy.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Marcotte E, Chand B. Management and prevention of surgical and nutritional complications after bariatric surgery. Surg Clin North Am 2016;96:843–56. https://doi.org/10.1016/j.suc.2016.03.006 . - DOI - PubMed
    1. Angrisani L, Santonicola A, Iovino P, Vitiello A, Zundel N, Buchwald H, et al. Bariatric surgery and endoluminal procedures: IFSO Worldwide Survey 2014. Obes Surg 2017;27:2279–89. https://doi.org/10.1007/s11695-017-2666-x . - DOI - PubMed - PMC
    1. Phillips BT, Shikora SA. The history of metabolic and bariatric surgery: development of standards for patient safety and efficacy. Metabolism 2018;79:97–107. https://doi.org/10.1016/j.metabol.2017.12.010 . - DOI - PubMed
    1. Sharples AJ, Mahawar K. Systematic review and meta-analysis of randomised controlled trials comparing long-term outcomes of roux-en-y gastric bypass and sleeve gastrectomy. Obes Surg 2020;30:664–72. https://doi.org/10.1007/s11695-019-04235-2 . - DOI - PubMed
    1. Mingrone G, Panunzi S, De Gaetano A, Guidone C, Iaconelli A, Nanni G, et al. Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial. Lancet 2015;386:964–73. https://doi.org/10.1016/S0140-6736(15)00075-6 . - DOI - PubMed

MeSH terms